{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:31:28Z","timestamp":1793082688204,"version":"4.5.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Sarcoidosis is a chronic granulomatous disease that can virtually affect any organ. Its etiology is unknown, although it has been proposed that environmental or biological agents can act as triggers, ultimately leading to chronic inflammation in genetically predisposed individuals. The main component of sarcoid inflammation is represented by an exaggerated T- lymphocytic cellular response to a putative antigen that could not be efficiently cleared in the patient. However, several clinical and immunological observations, such as the association of sarcoidosis to autoimmune diseases or the presence of autoantibodies in the serum of patients with sarcoidosis, suggest that humoral-mediated immune response might also play a role in the pathogenesis of sarcoidosis. The aim of this review is to deepen the relationship between sarcoidosis and autoimmunity, by analyzing the most recent advances and proposing new fields of research.<\/jats:p>","DOI":"10.3389\/fmed.2022.991394","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T08:29:55Z","timestamp":1662452995000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Sarcoidosis and autoimmunity: In the depth of a complex relationship"],"prefix":"10.3389","volume":"9","author":[{"given":"Luigi","family":"Rizzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Sabb\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Suppressa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-019-0096-x","article-title":"Sarcoidosis","volume":"5","author":"Grunewald","year":"2019","journal-title":"Nat Rev Dis Primer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3390\/jcm9041081","article-title":"Sarcoidosis: causes, diagnosis, clinical features, and treatments","volume":"9","author":"Jain","year":"2020","journal-title":"J Clin Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3390\/cells10040766","article-title":"Sarcoidosis: a clinical overview from symptoms to diagnosis","volume":"10","author":"S\u00e8ve","year":"2021","journal-title":"Cells."},{"key":"B5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1164\/rccm.200608-1197OC","article-title":"Sex-specific manifestations of L\u00f6fgren's syndrome","volume":"175","author":"Grunewald","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1183\/09031936.00025011","article-title":"HLA-DRB1* alleles and symptoms associated with Heerfordt's syndrome in sarcoidosis","volume":"38","author":"Darlington","year":"2011","journal-title":"Eur Respir J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/17476348.2020.1721284","article-title":"Therapeutic strategies for pulmonary sarcoidosis","volume":"14","author":"James","year":"2020","journal-title":"Expert Rev Respir Med."},{"key":"B8","first-page":"149","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis American thoracic society\/European respiratory society\/world association of sarcoidosis and other granulomatous disorders","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"438070","DOI":"10.1155\/2014\/438070","article-title":"Bronchoalveolar lavage fluid IFN-\u03b3+ Th17 cells and regulatory t cells in pulmonary sarcoidosis","volume":"2014","author":"T\u00f8ndell","year":"2014","journal-title":"Mediators Inflamm"},{"key":"B10","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.autrev.2011.05.004","article-title":"Human FoxP3+ regulatory T cells in systemic autoimmune diseases","volume":"10","author":"Miyara","year":"2011","journal-title":"Autoimmun Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1002\/1521-4141(200209)32:9<2680::AID-IMMU2680>3.0.CO;2-6","article-title":"ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells","volume":"32","author":"Witsch","year":"2002","journal-title":"Eur J Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/cei.12715","article-title":"Pulmonary sarcoidosis is associated with high-level inducible co-stimulator (ICOS) expression on lung regulatory T cells\u2013possible implications for the ICOS\/ICOS-ligand axis in disease course and resolution","volume":"183","author":"Sakthivel","year":"2016","journal-title":"Clin Exp Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1080\/1744666X.2016.1181541","article-title":"Advances in understanding the immunopathology of sarcoidosis and implications on therapy","volume":"12","author":"Cinetto","year":"2016","journal-title":"Expert Rev Clin Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10238-021-00737-5","article-title":"Associations between sarcoidosis, autoimmune diseases, and autoantibodies: a single-center retrospective study in China","volume":"22","author":"Shi","year":"2022","journal-title":"Clin Exp Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.3390\/ijms21031138","article-title":"Natural autoantibodies in chronic pulmonary diseases","volume":"21","author":"Fukushima","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B16","first-page":"182","article-title":"Widespread heavy damage of capillary endothelial cells in the pathogenesis of sarcoidosis \u2013 evidence by monoclonal von Willebrand factor immunohistochemistry in the bronchus and lung of patients with sarcoidosis","volume":"31","author":"Mochizuki","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1002\/ijc.28273","article-title":"Macrophages in T cell\/histiocyte rich large B cell lymphoma strongly express metal-binding proteins and show a bi-activated phenotype","volume":"133","author":"Hartmann","year":"2013","journal-title":"Int J Cancer."},{"key":"B18","doi-asserted-by":"publisher","first-page":"20210","DOI":"10.1074\/jbc.M212669200","article-title":"Calcium- and cell cycle-dependent association of annexin 11 with the nuclear envelope","volume":"278","author":"Tomas","year":"2003","journal-title":"J Biol Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"eaad9157","DOI":"10.1126\/scitranslmed.aad9157","article-title":"Mutations in the vesicular tracking protein annexin A11 are associated with amyotrophic lateral sclerosis","volume":"9","author":"Smith","year":"2017","journal-title":"Sci Transl Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1164\/rccm.201407-1341OC","article-title":"Proteomic profiling reveals autoimmune targets in sarcoidosis","volume":"191","author":"H\u00e4ggmark","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1183\/09031936.00178111","article-title":"Quantitative intact proteomics investigations of alveolar macrophages in sarcoidosis","volume":"41","author":"Silva","year":"2013","journal-title":"Eur Respir J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.yexcr.2007.03.040","article-title":"Novel functions of vimentin in cell adhesion, migration, and signaling","volume":"313","author":"Ivaska","year":"2007","journal-title":"Exp Cell Res"},{"key":"B23","first-page":"125","article-title":"Cross-reactive and species specific Mycobacterium tuberculosis antigens in the immunoprofile of Schaumann bodies: a major clue to the etiology of sarcoidosis","volume":"11","author":"Ang","year":"1996","journal-title":"Histol Histopathol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/BF02890384","article-title":"A comparison with electron microscopic findings","volume":"42","year":"1983","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"12877","DOI":"10.1073\/pnas.162488599","article-title":"Diversity, topographic differentiation, and positional memory in human fibroblasts","volume":"99","author":"Chang","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0170285","DOI":"10.1371\/journal.pone.0170285","article-title":"Proteomic analysis of Kveim reagent identifies targets of cellular immunity in sarcoidosis","volume":"12","author":"Eberhardt","year":"2017","journal-title":"PLoS ONE."},{"key":"B27","first-page":"86","article-title":"The preparation and standardization of Kveim testing antigen","volume":"2","author":"Chase","year":"1961","journal-title":"Am Rev Respir Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3389\/fimmu.2018.01516","article-title":"In situ humoral immunity to vimentin in HLA- DRB1*03+ patients with pulmonary sarcoidosis.","volume":"9","author":"Kinloch","year":"2018","journal-title":"Front. Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"100153","DOI":"10.1016\/j.jtauto.2022.100153","article-title":"Systemic immune response to vimentin and granuloma formation in a model of pulmonary sarcoidosis","volume":"5","author":"Bagavant","year":"2022","journal-title":"J Transl Autoimmun"},{"key":"B30","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.autrev.2018.04.004","article-title":"Vimentin as antigenic target in autoimmunity: a comprehensive review","volume":"17","author":"Mikhailova","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1080\/07853890.2022.2063375","article-title":"Comorbities of sarcoidosis","volume":"54","author":"Tana","year":"2022","journal-title":"Ann Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1046\/j.1365-2265.1997.1630976.x","article-title":"High incidence of positive autoantibodies against thyroid peroxidase and thyroglobulin in patients with sarcoidosis","volume":"46","author":"Nakamura","year":"1997","journal-title":"Clin Endocrinol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1378\/chest.130.2.526","article-title":"Prevalence of hypothyroidism and Graves disease in sarcoidosis","volume":"130","author":"Antonelli","year":"2006","journal-title":"Chest."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.rmed.2013.01.004","article-title":"Concomitant sarcoidosis and a connective tissue disease: review of the clinical findings and postulations concerning their association","volume":"107","author":"Judson","year":"2013","journal-title":"Respir Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1183\/1025448x.00032015","article-title":"Rare manifestations of sarcoidosis","volume":"32","author":"Moller","year":"2005","journal-title":"Eur Respir Monograph"},{"key":"B36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0002-9343(63)90165-7","article-title":"Manifestations of sarcoidosis. Analysis of 145 patients, with a review of nine series selected from the literature","volume":"35","author":"Maycock","year":"1963","journal-title":"Am J Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1046\/j.1365-2796.1999.00451.x","article-title":"Evidence of gastrointestinal immune reactivity in patients with sarcoidosis","volume":"245","author":"Papadopoulos","year":"1999","journal-title":"J Intern Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/j.1600-6143.2006.01288.x","article-title":"Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action","volume":"6","author":"Pescovitz","year":"2006","journal-title":"Am J Transpl."},{"key":"B39","doi-asserted-by":"publisher","first-page":"80343","DOI":"10.2165\/00003495-200363080-00005","article-title":"Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia","volume":"63","author":"Plosker","year":"2003","journal-title":"Drugs."},{"key":"B40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/rheumatology\/40.2.205","article-title":"Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes","volume":"40","author":"Edwards","year":"2001","journal-title":"Rheumatology."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1002\/art.10541","article-title":"An open study of B lymphocyte depletion in systemic lupus erythematosus","volume":"46","author":"Leandro","year":"2002","journal-title":"Arthritis Rheum."},{"key":"B42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.18773\/austprescr.2016.053","article-title":"Rituximab in autoimmune diseases","volume":"39","author":"Randall","year":"2016","journal-title":"Australian prescriber."},{"key":"B43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/rheumatology\/kev309","article-title":"Successful use of rituximab in refractory cardiac sarcoidosis","volume":"55","author":"Krause","year":"2015","journal-title":"Rheumatology."},{"key":"B44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12948-015-0025-9","article-title":"Rituximab in refractory sarcoidosis: a single centre experience","volume":"13","author":"Cinetto","year":"2015","journal-title":"Clin Mol Allergy."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet."},{"key":"B46","doi-asserted-by":"publisher","first-page":"877303","DOI":"10.3389\/fimmu.2022.877303","article-title":"From COVID-19 to sarcoidosis: how similar are these two diseases?","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"102824","DOI":"10.1016\/j.autrev.2021.102824","article-title":"Granulomatous manifestations associated with COVID19 infection: is there a link between these two diseases?","volume":"20","author":"Mertz","year":"2021","journal-title":"Autoimmun Rev."},{"key":"B48","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/jmv.25785","article-title":"Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19","volume":"92","author":"Cheng","year":"2020","journal-title":"J Med Virol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jjcc.2019.05.007","article-title":"Reconsideration of the cut-off value of angiotensin-converting enzyme for screening of sarcoidosis in Japanese patients","volume":"74","author":"Baba","year":"2019","journal-title":"J Cardiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1056\/NEJMoa030747","article-title":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","volume":"348","author":"Drosten","year":"2003","journal-title":"N Engl J Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S1473-3099(20)30434-5","article-title":"pulmonary post-mortem findings in a series of COVID-19 cases from northern italy: a two-centre descriptive study","volume":"20","author":"Carsana","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/s41598-020-57741-0","article-title":"Imbalance in B cell and T follicular helper cell subsets in pulmonary sarcoidosis","volume":"10","author":"Kudryavtsev","year":"2020","journal-title":"Sci Rep."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.3390\/v13101966","article-title":"Imbalanced Immune Response of T-cell and B-cell subsets in patients with moderate and severe COVID-19","volume":"13","author":"Golovkin","year":"2021","journal-title":"Viruses"},{"key":"B54","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1172\/JCI110036","article-title":"Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes","volume":"67","author":"Hunninghake","year":"1981","journal-title":"J Clin Invest."},{"key":"B55","doi-asserted-by":"publisher","first-page":"365","DOI":"10.5858\/2002-126-0365-MMIAWS","article-title":"Multiple myeloma in association with sarcoidosis","volume":"126","author":"Sen","year":"2002","journal-title":"Arch Pathol Lab Med."},{"key":"B56","first-page":"209","article-title":"Sarcoidosis: developments in etiology, immunology and therapeutics","volume":"45","author":"Vourlekis","year":"2000","journal-title":"Adv Intern Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jaut.2018.10.012","article-title":"Molecular mimicry and autoimmunity","volume":"95","author":"Rojas","year":"2018","journal-title":"J Autoimmun"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/829129","article-title":"Guillain-barre syndrome animal model: the first proof of molecular mimicry in human autoimmune disorder","author":"Shahrizaila","year":"2011","journal-title":"J. Biomed. Biotechnol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.991394\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T08:30:04Z","timestamp":1662453004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.991394\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":58,"alternative-id":["10.3389\/fmed.2022.991394"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.991394","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,6]]},"article-number":"991394"}}